{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:29:18Z","timestamp":1793572158711,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"DOI":"10.1007\/s12017-025-08901-w","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:14:25Z","timestamp":1771485265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Searching for New Possible Peripheral Biomarkers of Cognitive Decline in Down Syndrome: The Role of IL-18 Pathway and its Interaction with TGF-\u03b21 and TNF-\u03b1"],"prefix":"10.1007","volume":"28","author":[{"given":"Margherita","family":"Grasso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Fidilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"L\u2019Episcopo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Recupero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lovino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Alboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Bacalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafino","family":"Buono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"De La Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Tascedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna MC","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Benatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Caraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"8901_CR1","doi-asserted-by":"publisher","first-page":"718426","DOI":"10.3389\/fnagi.2021.718426","volume":"13","author":"MM Ahmed","year":"2021","unstructured":"Ahmed, M. M., Johnson, N. R., Boyd, T. D., Coughlan, C., Chial, H. J., & Potter, H. (2021). Innate immune system activation and neuroinflammation in down syndrome and neurodegeneration: Therapeutic targets or partners? Frontiers in Aging Neuroscience, 13, 718426. https:\/\/doi.org\/10.3389\/fnagi.2021.718426","journal-title":"Frontiers in Aging Neuroscience"},{"key":"8901_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-9","volume":"7","author":"S Alboni","year":"2010","unstructured":"Alboni, S., Cervia, D., Sugama, S., & Conti, B. (2010). Interleukin 18 in the CNS. Journal of Neuroinflammation, 7, Article 9. https:\/\/doi.org\/10.1186\/1742-2094-7-9","journal-title":"Journal of Neuroinflammation"},{"issue":"7","key":"8901_CR3","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1038\/s41380-025-02951-z","volume":"30","author":"S Alboni","year":"2025","unstructured":"Alboni, S., Tascedda, F., Uezato, A., Sugama, S., Chen, Z., Marcondes, M. C. G., et al. (2025). Interleukin 18 and the brain: Neuronal functions, neuronal survival and psycho-neuro-immunology during stress. Molecular Psychiatry, 30(7), 3197\u20133208. https:\/\/doi.org\/10.1038\/s41380-025-02951-z","journal-title":"Molecular Psychiatry"},{"issue":"3","key":"8901_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1684\/ecn.2011.0288","volume":"22","author":"D Boraschi","year":"2011","unstructured":"Boraschi, D., Lucchesi, D., Hainzl, S., Leitner, M., Maier, E., Mangelberger, D., et al. (2011). IL-37: A new anti-inflammatory cytokine of the IL-1 family. European Cytokine Network, 22(3), 127\u2013147. https:\/\/doi.org\/10.1684\/ecn.2011.0288","journal-title":"European Cytokine Network"},{"issue":"4","key":"8901_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bbi.2007.10.001","volume":"22","author":"P Boss\u00f9","year":"2008","unstructured":"Boss\u00f9, P., Ciaramella, A., Salani, F., Bizzoni, F., Varsi, E., Di Iulio, F., et al. (2008). Interleukin-18 produced by peripheral blood cells is increased in alzheimer\u2019s disease and correlates with cognitive impairment. Brain, Behavior, and Immunity, 22(4), 487\u2013492. https:\/\/doi.org\/10.1016\/j.bbi.2007.10.001","journal-title":"Brain, Behavior, and Immunity"},{"key":"8901_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00389","volume":"7","author":"F Caraci","year":"2016","unstructured":"Caraci, F., Tascedda, F., Merlo, S., Benatti, C., Spampinato, S. F., Munaf\u00f2, A., et al. (2016). Fluoxetine prevents A\u03b2(1\u201342)-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-\u03b21. Frontiers in Pharmacology, 7, Article 389. https:\/\/doi.org\/10.3389\/fphar.2016.00389","journal-title":"Frontiers in Pharmacology"},{"key":"8901_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.phrs.2018.02.007","volume":"130","author":"F Caraci","year":"2018","unstructured":"Caraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., et al. (2018). Neurobiological links between depression and AD: The role of TGF-\u03b21 signaling as a new pharmacological target. Pharmacological Research, 130, 374\u2013384. https:\/\/doi.org\/10.1016\/j.phrs.2018.02.007","journal-title":"Pharmacological Research"},{"issue":"1","key":"8901_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.18632\/aging.206188","volume":"17","author":"D Cheishvili","year":"2025","unstructured":"Cheishvili, D., Do Carmo, S., Caraci, F., Grasso, M., Cuello, A. C., & Szyf, M. (2025). EpiAge: A next-generation sequencing-based ELOVL2 epigenetic clock for biological age assessment in saliva and blood across health and disease. Aging (Albany NY), 17(1), 131\u2013160. https:\/\/doi.org\/10.18632\/aging.206188","journal-title":"Aging (Albany NY)"},{"key":"8901_CR9","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.2147\/jir.s280953","volume":"14","author":"H Chung","year":"2021","unstructured":"Chung, H., Green, P. H. R., Wang, T. C., & Kong, X. F. (2021). Interferon-driven immune dysregulation in down syndrome: A review of the evidence. Journal of Inflammation Research, 14, 5187\u20135200. https:\/\/doi.org\/10.2147\/jir.s280953","journal-title":"Journal of Inflammation Research"},{"key":"8901_CR10","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202302399","author":"R D\u00edaz-Pino","year":"2024","unstructured":"D\u00edaz-Pino, R., Rice, G. I., San Felipe, D., Pepanashvili, T., Kasher, P. R., Briggs, T. A., et al. (2024). Type I interferon regulates interleukin-1beta and IL-18 production and secretion in human macrophages. Life Science Alliance. https:\/\/doi.org\/10.26508\/lsa.202302399","journal-title":"Life Science Alliance"},{"issue":"12","key":"8901_CR11","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.2174\/1389203719666171129094937","volume":"19","author":"LD Estrada","year":"2018","unstructured":"Estrada, L. D., Oliveira-Cruz, L., & Cabrera, D. (2018). Transforming growth factor beta type I role in neurodegeneration: Implications for Alzheimer\u00b4s disease. Current Protein and Peptide Science, 19(12), 1180\u20131188. https:\/\/doi.org\/10.2174\/1389203719666171129094937","journal-title":"Current Protein and Peptide Science"},{"issue":"9","key":"8901_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tins.2005.06.008","volume":"28","author":"U Felderhoff-Mueser","year":"2005","unstructured":"Felderhoff-Mueser, U., Schmidt, O. I., Oberholzer, A., B\u00fchrer, C., & Stahel, P. F. (2005). IL-18: A key player in neuroinflammation and neurodegeneration? Trends in Neurosciences, 28(9), 487\u2013493. https:\/\/doi.org\/10.1016\/j.tins.2005.06.008","journal-title":"Trends in Neurosciences"},{"issue":"12","key":"8901_CR13","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1093\/brain\/awaa326","volume":"143","author":"L Flores-Aguilar","year":"2020","unstructured":"Flores-Aguilar, L., Iulita, M. F., Kovecses, O., Torres, M. D., Levi, S. M., Zhang, Y., et al. (2020). Evolution of neuroinflammation across the lifespan of individuals with down syndrome. Brain, 143(12), 3653\u20133671. https:\/\/doi.org\/10.1093\/brain\/awaa326","journal-title":"Brain"},{"issue":"10242","key":"8901_CR14","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/s0140-6736(20)30689-9","volume":"395","author":"J Fortea","year":"2020","unstructured":"Fortea, J., Vilaplana, E., Carmona-Iragui, M., Benejam, B., Videla, L., Barroeta, I., et al. (2020). Clinical and biomarker changes of Alzheimer\u2019s disease in adults with Down syndrome: A cross-sectional study. Lancet, 395(10242), 1988\u20131997. https:\/\/doi.org\/10.1016\/s0140-6736(20)30689-9","journal-title":"Lancet"},{"issue":"26","key":"8901_CR15","doi-asserted-by":"publisher","first-page":"eadg6218","DOI":"10.1126\/sciadv.adg6218","volume":"9","author":"MD Galbraith","year":"2023","unstructured":"Galbraith, M. D., Rachubinski, A. L., Smith, K. P., Araya, P., Waugh, K. A., Enriquez-Estrada, B., et al. (2023). Multidimensional definition of the interferonopathy of down syndrome and its response to JAK inhibition. Science Advances, 9(26), eadg6218. https:\/\/doi.org\/10.1126\/sciadv.adg6218","journal-title":"Science Advances"},{"key":"8901_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.987212","volume":"16","author":"O Garc\u00eda","year":"2022","unstructured":"Garc\u00eda, O., & Flores-Aguilar, L. (2022). Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer\u2019s disease. Frontiers in Cellular Neuroscience, 16, Article 987212. https:\/\/doi.org\/10.3389\/fncel.2022.987212","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"8901_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-981-13-3681-2_7","volume":"91","author":"N Gensous","year":"2019","unstructured":"Gensous, N., Franceschi, C., Salvioli, S., Garagnani, P., & Bacalini, M. G. (2019). Down syndrome, ageing and epigenetics. Subcellular Biochemistry, 91, 161\u2013193. https:\/\/doi.org\/10.1007\/978-981-13-3681-2_7","journal-title":"Subcellular Biochemistry"},{"issue":"12","key":"8901_CR18","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","volume":"55","author":"C Girard","year":"2016","unstructured":"Girard, C., Rech, J., Brown, M., Allali, D., Roux-Lombard, P., Spertini, F., et al. (2016). Elevated serum levels of free interleukin-18 in adult-onset Still\u2019s disease. Rheumatology (Oxford, England), 55(12), 2237\u20132247. https:\/\/doi.org\/10.1093\/rheumatology\/kew300","journal-title":"Rheumatology (Oxford, England)"},{"key":"8901_CR19","doi-asserted-by":"publisher","first-page":"1379965","DOI":"10.3389\/fphar.2024.1379965","volume":"15","author":"M Grasso","year":"2024","unstructured":"Grasso, M., Fidilio, A., L\u2019Episcopo, F., Recupero, M., Barone, C., Bacalini, M. G., et al. (2024). Low TGF-\u03b21 plasma levels are associated with cognitive decline in down syndrome. Frontiers in Pharmacology, 15, 1379965. https:\/\/doi.org\/10.3389\/fphar.2024.1379965","journal-title":"Frontiers in Pharmacology"},{"issue":"8","key":"8901_CR20","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1007\/s10072-025-08195-7","volume":"46","author":"N Grotteschi","year":"2025","unstructured":"Grotteschi, N., Rochat, M. J., Pollarini, V., Ghezzo, A., Pellegrini, C., Calandra-Buonaura, G., et al. (2025). Neurological findings in a cohort of adults with down syndrome. Neurological Sciences, 46(8), 3639\u20133649. https:\/\/doi.org\/10.1007\/s10072-025-08195-7","journal-title":"Neurological Sciences"},{"key":"8901_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155781","volume":"150","author":"M Harel","year":"2022","unstructured":"Harel, M., Fauteux-Daniel, S., Girard-Guyonvarc\u2019h, C., & Gabay, C. (2022). Balance between Interleukin-18 and Interleukin-18 binding protein in auto-inflammatory diseases. Cytokine, 150, Article 155781. https:\/\/doi.org\/10.1016\/j.cyto.2021.155781","journal-title":"Cytokine"},{"issue":"11","key":"8901_CR22","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jalz.2016.05.001","volume":"12","author":"MF Iulita","year":"2016","unstructured":"Iulita, M. F., Ower, A., Barone, C., Pentz, R., Gubert, P., Romano, C., et al. (2016). An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation. Alzheimer\u2019s & Dementia, 12(11), 1132\u20131148. https:\/\/doi.org\/10.1016\/j.jalz.2016.05.001","journal-title":"Alzheimer's & Dementia"},{"issue":"5","key":"8901_CR23","doi-asserted-by":"publisher","first-page":"e2212910","DOI":"10.1001\/jamanetworkopen.2022.12910","volume":"5","author":"MF Iulita","year":"2022","unstructured":"Iulita, M. F., Garz\u00f3n Chavez, D., Klitgaard Christensen, M., Valle Tamayo, N., Plana-Ripoll, O., Rasmussen, S. A., et al. (2022). Association of alzheimer disease with life expectancy in people with down syndrome. JAMA Network Open, 5(5), e2212910. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.12910","journal-title":"JAMA Network Open"},{"issue":"2","key":"8901_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad074","volume":"5","author":"MF Iulita","year":"2023","unstructured":"Iulita, M. F., Bejanin, A., Vilaplana, E., Carmona-Iragui, M., Benejam, B., Videla, L., et al. (2023). Association of biological sex with clinical outcomes and biomarkers of Alzheimer\u2019s disease in adults with Down syndrome. Brain Communications, 5(2), Article fcad074. https:\/\/doi.org\/10.1093\/braincomms\/fcad074","journal-title":"Brain Communications"},{"issue":"3","key":"8901_CR25","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1073\/pnas.97.3.1190","volume":"97","author":"SH Kim","year":"2000","unstructured":"Kim, S. H., Eisenstein, M., Reznikov, L., Fantuzzi, G., Novick, D., Rubinstein, M., et al. (2000). Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proceedings of the National Academy of Sciences of the United States of America, 97(3), 1190\u20131195. https:\/\/doi.org\/10.1073\/pnas.97.3.1190","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"8901_CR26","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1002\/alz.13779","volume":"20","author":"FK Larsen","year":"2024","unstructured":"Larsen, F. K., Baksh, R. A., McGlinchey, E., Langballe, E. M., Benejam, B., Beresford-Webb, J., et al. (2024). Age of Alzheimer\u2019s disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium. Alzheimer\u2019s & Dementia, 20(5), 3270\u20133280. https:\/\/doi.org\/10.1002\/alz.13779","journal-title":"Alzheimer's & Dementia"},{"issue":"7","key":"8901_CR27","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.acra.2013.03.009","volume":"20","author":"D Liu","year":"2013","unstructured":"Liu, D., & Zhou, X. H. (2013). ROC analysis in biomarker combination with covariate adjustment. Academic Radiology, 20(7), 874\u2013882. https:\/\/doi.org\/10.1016\/j.acra.2013.03.009","journal-title":"Academic Radiology"},{"issue":"4","key":"8901_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1684\/ecn.2010.0210","volume":"21","author":"P Migliorini","year":"2010","unstructured":"Migliorini, P., Anzilotti, C., Pratesi, F., Quattroni, P., Bargagna, M., Dinarello, C. A., et al. (2010). Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus. European Cytokine Network, 21(4), 264\u2013271. https:\/\/doi.org\/10.1684\/ecn.2010.0210","journal-title":"European Cytokine Network"},{"issue":"4","key":"8901_CR29","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.4049\/jimmunol.0902153","volume":"185","author":"JM Millward","year":"2010","unstructured":"Millward, J. M., L\u00f8bner, M., Wheeler, R. D., & Owens, T. (2010). Inflammation in the central nervous system and Th17 responses are inhibited by IFN-gamma-Induced IL-18 binding protein. Journal of Immunology (Baltimore, Md.\u202f: 1950), 185(4), 2458\u20132466. https:\/\/doi.org\/10.4049\/jimmunol.0902153","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"key":"8901_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413505","author":"D Novick","year":"2024","unstructured":"Novick, D. (2024). IL-18 and IL-18BP: A Unique Dyad in Health and Disease. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms252413505","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"8901_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70535","volume":"21","author":"S Palmqvist","year":"2025","unstructured":"Palmqvist, S., Whitson, H. E., Allen, L. A., Suarez-Calvet, M., Galasko, D., Karikari, T. K., et al. (2025). Alzheimer\u2019s Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer\u2019s disease within specialized care settings. Alzheimer\u2019s & Dementia, 21(7), Article e70535. https:\/\/doi.org\/10.1002\/alz.70535","journal-title":"Alzheimer's & Dementia"},{"issue":"1","key":"8901_CR32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1186\/s12967-025-06652-7","volume":"23","author":"I Papatheodorou","year":"2025","unstructured":"Papatheodorou, I., Bla\u017ekov\u00e1, G., Bos\u00e1kov\u00e1, V., Tom\u00e1\u0161ikov\u00e1, Z., Spearing, E., Klieber, R., et al. (2025). Redefining the role of IL-18 in post-surgical recovery and sepsis: A key mediator of inflammation resolution. Journal of Translational Medicine, 23(1), 728. https:\/\/doi.org\/10.1186\/s12967-025-06652-7","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"8901_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14364","volume":"21","author":"ME Petersen","year":"2025","unstructured":"Petersen, M. E., Flores-Aguilar, L., Head, E., Montoliu-Gaya, L., Strydom, A., Pape, S. E., et al. (2025). Blood biomarkers in Down syndrome: Facilitating Alzheimer\u2019s disease detection and monitoring. Alzheimer\u2019s & Dementia, 21(1), Article e14364. https:\/\/doi.org\/10.1002\/alz.14364","journal-title":"Alzheimer's & Dementia"},{"key":"8901_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.trci.2018.10.006","volume":"4","author":"A Strydom","year":"2018","unstructured":"Strydom, A., Coppus, A., Blesa, R., Danek, A., Fortea, J., Hardy, J., et al. (2018). Alzheimer\u2019s disease in Down syndrome: An overlooked population for prevention trials. Alzheimer\u2019s & Dementia (New York, N. Y.), 4, 703\u2013713. https:\/\/doi.org\/10.1016\/j.trci.2018.10.006","journal-title":"Alzheimer's & Dementia (New York, N. Y.)"},{"key":"8901_CR35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.16220","author":"KD Sullivan","year":"2016","unstructured":"Sullivan, K. D., Lewis, H. C., Hill, A. A., Pandey, A., Jackson, L. P., Cabral, J. M., et al. (2016). Trisomy 21 consistently activates the interferon response. eLife. https:\/\/doi.org\/10.7554\/eLife.16220","journal-title":"eLife"},{"key":"8901_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1742-2094-9-199","volume":"9","author":"EM Sutinen","year":"2012","unstructured":"Sutinen, E. M., Pirttil\u00e4, T., Anderson, G., Salminen, A., & Ojala, J. O. (2012). Pro-inflammatory interleukin-18 increases alzheimer\u2019s disease-associated amyloid-\u03b2 production in human neuron-like cells. Journal of Neuroinflammation, 9, 199. https:\/\/doi.org\/10.1186\/1742-2094-9-199","journal-title":"Journal of Neuroinflammation"},{"issue":"12","key":"8901_CR37","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/jir.12901","volume":"65","author":"ER Wallace","year":"2021","unstructured":"Wallace, E. R., Harp, J. P., Van Pelt, K. L., Koehl, L. M., Caban-Holt, A. M., Anderson-Mooney, A. J., et al. (2021). Identifying dementia in Down syndrome with the Severe Impairment Battery, Brief Praxis Test and Dementia Scale for People with Learning Disabilities. Journal of Intellectual Disability Research, 65(12), 1085\u20131096. https:\/\/doi.org\/10.1111\/jir.12901","journal-title":"Journal of Intellectual Disability Research"},{"issue":"6","key":"8901_CR38","doi-asserted-by":"publisher","DOI":"10.3892\/br.2024.1775","volume":"20","author":"F Wang","year":"2024","unstructured":"Wang, F. (2024). Interleukin\u201118 binding protein: Biological properties and roles in human and animal immune regulation (Review). Biomedical Reports, 20(6), Article 87. https:\/\/doi.org\/10.3892\/br.2024.1775","journal-title":"Biomedical Reports"},{"key":"8901_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.bbi.2020.04.004","volume":"88","author":"D Wu","year":"2020","unstructured":"Wu, D., Zhang, G., Zhao, C., Yang, Y., Miao, Z., & Xu, X. (2020). Interleukin-18 from neurons and microglia mediates depressive behaviors in mice with post-stroke depression. Brain, Behavior, and Immunity, 88, 411\u2013420. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.004","journal-title":"Brain, Behavior, and Immunity"},{"issue":"48","key":"8901_CR40","doi-asserted-by":"publisher","first-page":"84489","DOI":"10.18632\/oncotarget.21060","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Che, M., Yuan, J., Yu, Y., Cao, C., Qin, X. Y., et al. (2017). Aberrations in circulating inflammatory cytokine levels in patients with down syndrome: A meta-analysis. Oncotarget, 8(48), 84489\u201384496. https:\/\/doi.org\/10.18632\/oncotarget.21060","journal-title":"Oncotarget"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-025-08901-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12017-025-08901-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-025-08901-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:14:26Z","timestamp":1771485266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12017-025-08901-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8901"],"URL":"https:\/\/doi.org\/10.1007\/s12017-025-08901-w","relation":{},"ISSN":["1559-1174"],"issn-type":[{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Oasi Research Institute-IRCCS (2021\/02\/16\/CE-IRCCS-OASI\/PA17, grant no.: GR-2019-12369983).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}],"article-number":"12"}}